These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20348881)

  • 1. Phosphorylated ezrin is located in the nucleus of the osteosarcoma cell.
    Di Cristofano C; Leopizzi M; Miraglia A; Sardella B; Moretti V; Ferrara A; Petrozza V; Della Rocca C
    Mod Pathol; 2010 Jul; 23(7):1012-20. PubMed ID: 20348881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ezrin and moesin expression in canine and feline osteosarcoma.
    Hlavaty J; Wolfesberger B; Hauck M; Obermayer-Pietsch B; Fuchs-Baumgartinger A; Miller I; Walter I
    Histol Histopathol; 2017 Aug; 32(8):805-816. PubMed ID: 27900754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC.
    Ren L; Hong SH; Cassavaugh J; Osborne T; Chou AJ; Kim SY; Gorlick R; Hewitt SM; Khanna C
    Oncogene; 2009 Feb; 28(6):792-802. PubMed ID: 19060919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezrin/NF-κB Pathway Regulates EGF-induced Epithelial-Mesenchymal Transition (EMT), Metastasis, and Progression of Osteosarcoma.
    Liu P; Yang P; Zhang Z; Liu M; Hu S
    Med Sci Monit; 2018 Apr; 24():2098-2108. PubMed ID: 29628496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
    Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
    Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas.
    Salas S; Bartoli C; Deville JL; Gaudart J; Fina F; Calisti A; Bollini G; Curvale G; Gentet JC; Duffaud F; Figarella-Branger D; Bouvier C
    Virchows Arch; 2007 Dec; 451(6):999-1007. PubMed ID: 17786474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
    Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
    Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezrin expression predicts survival in stage IIB osteosarcomas.
    Kim MS; Song WS; Cho WH; Lee SY; Jeon DG
    Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of the Rac1/RhoA pathway with ezrin expression in osteosarcoma.
    Chiappetta C; Leopizzi M; Censi F; Puggioni C; Petrozza V; Rocca CD; Di Cristofano C
    Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):162-70. PubMed ID: 24614149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prognostic Role of Ezrin and HER2/neu Expression in Osteosarcoma.
    Abdou AG; Kandil M; Asaad NY; Dawoud MM; Shahin AA; Abd Eldayem AF
    Appl Immunohistochem Mol Morphol; 2016; 24(5):355-63. PubMed ID: 26067138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma.
    Mu Y; Zhang H; Che L; Li K
    Med Oncol; 2014 Feb; 31(2):821. PubMed ID: 24352761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ezrin in osteosarcoma metastasis.
    Ren L; Khanna C
    Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of ezrin and metastatic tumor antigen in osteosarcomas of the jaw.
    Park HR; Cabrini RL; Araujo ES; Paparella ML; Brandizzi D; Park YK
    Tumori; 2009; 95(1):81-6. PubMed ID: 19366061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis.
    Khanna C; Wan X; Bose S; Cassaday R; Olomu O; Mendoza A; Yeung C; Gorlick R; Hewitt SM; Helman LJ
    Nat Med; 2004 Feb; 10(2):182-6. PubMed ID: 14704791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ezrin immunohistochemical expression in chondrosarcomas, osteosarcomas and Ewing sarcoma family of tumors.
    Machado I; Navarro S; Giner F; Alberghini M; Bertoni F; Llombart-Bosch A
    Virchows Arch; 2010 Jul; 457(1):87-9. PubMed ID: 20552365
    [No Abstract]   [Full Text] [Related]  

  • 16. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
    Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
    Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ezrin immunohistochemical expression in cartilaginous tumours: a useful tool for differential diagnosis between chondroblastic osteosarcoma and chondrosarcoma.
    Salas S; de Pinieux G; Gomez-Brouchet A; Larrousserie F; Leroy X; Aubert S; Decouvelaere AV; Giorgi R; Fernandez C; Bouvier C
    Virchows Arch; 2009 Jan; 454(1):81-7. PubMed ID: 19050913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells.
    Zhao H; Guo M; Zhao G; Ma Q; Ma B; Qiu X; Fan Q
    Int J Mol Med; 2012 Nov; 30(5):1013-20. PubMed ID: 22922800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of ezrin phosphorylation prevents metastasis and alters cellular metabolism in osteosarcoma.
    Ren L; Hong SH; Chen QR; Briggs J; Cassavaugh J; Srinivasan S; Lizardo MM; Mendoza A; Xia AY; Avadhani N; Khan J; Khanna C
    Cancer Res; 2012 Feb; 72(4):1001-12. PubMed ID: 22147261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoexpression of Ezrin and CD44 in patients with osteosarcoma.
    Boldrini E; Peres SV; Morini S; de Camargo B
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):e213-7. PubMed ID: 20562647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.